Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.
Bristol Myers Squibb on Thursday posted better-than-expected fourth quarter earnings, but said its 2025 revenue would fall ...
Allstate Corp (ALL) shares rose 2.1% in premarket trade on Thursday after the company’s fourth-quarter earnings topped Wall ...
The automaker forecast overall profitability for 2025, but even that was lower than in 2024. For the fourth quarter, it ...
Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.
Adjusted EBITDA of $996 M for the fourth quarter, $3,684 Mfor the full year;R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x ;R&D Solutions contracted ...
Fred Alger Management, an investment management company, released its “Alger Spectra Fund” fourth quarter 2024 investor ...
Kenvue posted mixed Q4 earnings, with in-line EPS but revenue below estimates, driven by challenges in its Skin Health and ...
System-wide comparable RevPAR increased 3.5% and 2.7%, on a currency neutral basis, for the fourth quarter and full year, respectively, ...